Most Community Behavioral Health Clinics Still Skip Long-Acting Injectable Opioid Treatment, Study Finds
A new cross-sectional study finds that fewer than one in four certified community behavioral health clinics offering opioid use disorder ...
A new cross-sectional study finds that fewer than one in four certified community behavioral health clinics offering opioid use disorder ...
A new collection of seven studies in Frontiers in Adolescent Medicine shows that family, peers, recovery identity, and youth-specific programs ...
A survey of 600 US pediatric prescribers finds that legal uncertainty, practice setting, and beliefs about medication, rather than clinician ...
A national cohort study finds that opioid use disorder, stimulant use disorder, or both significantly increase the odds of unplanned ...
A multi-site clinical trial found that integrating pharmacists into primary care teams for opioid use disorder treatment was feasible, acceptable, ...
Physicians warn that decades-old immunoassay-based urine drug tests routinely produce false results that mislead clinicians and harm patients, calling for ...
A new review in Advances in Therapy finds that the psychedelic alkaloid ibogaine shows broad anti-addictive potential across opioid, stimulant, ...
CASPR and Allegheny County will launch a $13.3 million randomized trial of weekly semaglutide in up to 1,200 adults with ...
A nationally representative survey of 855 U.S. primary care and emergency department physicians finds that addiction training reduces provider stigma ...
A two-year hospital trial screening effort generated 9,140 flagged records but enrolled only 23 patients on buprenorphine, exposing both algorithmic ...
© 2025 Scienmag - Science Magazine
© 2025 Scienmag - Science Magazine